In vivo sites and cellular mechanisms of T reg cell-mediated suppression

Journal of Experimental Medicine

Volumn 203, Issue 3, 2006, Pages 489-492

  Rudensky, Alexander Y ^a   Campbell, Daniel J ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; GAMMA INTERFERON;

ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COMMUNICATION; CELL CONTACT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TARGET CELL; TISSUE;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; DENDRITIC CELLS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; T-LYMPHOCYTES, REGULATORY;

EID: 33645075732     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060214     Document Type: Review

References (24)

1. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat. Immunol. 6:345-352.
2. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338-344.
3. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 202:1075-1085.
4. Asseman, C., S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1004.
5. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T.W. Mak, and S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
6. Paust, S., L. Lu, N. McCarty, and H. Cantor. 2004. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA. 101:10398-10403.
7. Tang, Q., E.K. Boden, K.J. Henriksen, H. Bour-Jordan, M. Bi, and J.A. Bluestone. 2004. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34:2996-3005.
8. Shevach, E.M., C.A. Piccirillo, A.M. Thornton, and R.S. McHugh. 2003. Control of T cell activation by CD4+CD25+ suppressor T cells. Novartis Found. Symp. 252: 24-36; discussion 36-44, 106-114.
9. Grossman, W.J., J.W. Verbsky, W. Barchet, M. Colonna, J.P. Atkinson, and T.J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 21:589-601.
10. Gondek, D.C., L.F. Lu, S.A. Quezada, S. Sakaguchi, and R.J. Noelle. 2005. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174:1783-1786.
11. + T cells and dendritic cells in vivo. J. Exp. Med. 203:505-511.
12. Tang, Q., J.Y. Adams, A.J. Tooley, M. Bi, B.T. Fife, P. Serra, P. Santamaria, R.M. Locksley, M.F. Krummel, and J.A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7:83-92.
13. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
14. Chen, M.L., M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, H. von Boehmer, and K. Khazaie. 2005. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl. Acad. Sci. USA. 102:419-424.
15. Green, E.A., L. Gorelik, C.M. McGregor, E.H. Tran, and R.A. Flavell. 2003. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA. 100:10878-10883.
16. Fahlen, L., S. Read, L. Gorelik, S.D. Hurst, R.L. Coffman, R.A. Flavell, and F. Powrie. 2005. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 201:737-746.
17. + T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202:1387-1397.
18. Belkaid, Y., C.A. Piccirillo, S. Mendez, E.M. Shevach, and D.L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
19. Suffia, I., S.K. Reckling, G. Salay, and Y. Belkaid. 2005. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174:5444-5455.
20. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203:777-787.
21. Picca, C.C., and A.J. Caton. 2005. The role of self-peptides in the development of CD4+ CD25+ regulatory T cells. Curr. Opin. Immunol. 17:131-136.
22. Hsieh, C.S., and A.Y. Rudensky. 2005. The role of TCR specificity in naturally arising CD25+ CD4+ regulatory T cell biology. Curr. Top. Microbiol. Immunol. 293:25-42.
23. Hsieh, C.S., Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. Rudensky. 2004. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity. 21:267-277.
24. Hsieh, C.S., Y. Zheng, Y. Liang, J.D. Fontenot, and A.Y. Rudensky. 2006. An intersection between the self-reactive regulatory and non-regulatory T cell receptor repertoires. Nat. Immunol. In press.